30
HAWKHILL THERAPEUTICS Ltd raises $193K under Reg D
Company raise · Closed · Offering $193K · Sold $193K · Dundee, Scotland, United Kingdom · filed 2026-06-23
5
HAWKHILL THERAPEUTICS Ltd files Form D
Company raise update · Closed · Dundee, Scotland, United Kingdom · Form D/A filed 2026-09-29
How this compares
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
Sold rose from $193K to $291K (+$98K) in 98 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2026-06-23 | D | $193K | 1 | |
| 2026-09-29 | D/A | $291K | 1 | +$98K |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Hawkhill Therapeutics on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Timothy Jason Sparey | Director |
| Antoine Andrew Boulanger | Director |
| Christopher Andrew Woodland | Executive Officer, Director |
| Mary Andrew Canning | Director |
| Francisca Andrew Peixoto | Director |
Signed by Christopher Andrew Woodland, Director.
Why now — by persona
Relevant to: B2B software & services sales.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.